 |
PDBsum entry 4mlr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tunnel analysis for: 4mlr calculated with  MOLE 2.0
|
PDB id
|
|
|
|
4mlr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tunnels calculated on whole structure |
|
Tunnels calculated excluding ligands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
14 tunnels,
coloured by tunnel radius |
|
26 tunnels,
coloured by
tunnel radius
|
26 tunnels,
coloured as in
list below
|
|
|
|
|
|
Tunnels are interior spaces connected with the protein surrounding. Only channels longer than 15 Å are shown. |
|
|
|
|
|
|
|
Free R
|
|
|
|
|
|
|
Length
|
|
|
|
|
|
|
HPathy
|
|
|
|
|
|
|
HPhob
|
|
|
|
|
|
|
Polar
|
|
|
|
|
|
|
Rel Mut
|
|
|
|
|
|
|
Residue..type
|
|
|
|
|
|
|
Ligands
|
|
|
|
|
|
|
 |
Radius |
 |
1 |
 |
1.25 |
1.56 |
29.5 |
-0.88 |
-0.42 |
14.5 |
88 |
|
2 |
3 |
3 |
2 |
2 |
0 |
0 |
|
LYS 301 C
|
 |
|
2 |
 |
1.20 |
1.48 |
29.8 |
-0.92 |
-0.42 |
14.1 |
86 |
2 |
3 |
3 |
2 |
2 |
1 |
0 |
LYS 301 C
|
|
3 |
 |
1.22 |
1.47 |
33.2 |
-1.03 |
-0.36 |
17.4 |
87 |
3 |
4 |
3 |
2 |
2 |
0 |
0 |
LYS 301 C
|
|
4 |
 |
1.23 |
2.26 |
33.5 |
-1.15 |
-0.37 |
17.6 |
85 |
3 |
4 |
3 |
2 |
2 |
1 |
0 |
LYS 301 C
|
|
5 |
 |
1.21 |
1.54 |
44.7 |
0.33 |
0.13 |
4.1 |
85 |
2 |
1 |
3 |
9 |
4 |
0 |
0 |
KPI 166 C
|
|
6 |
 |
1.19 |
1.49 |
45.0 |
0.28 |
0.11 |
3.6 |
84 |
2 |
1 |
3 |
9 |
4 |
1 |
0 |
KPI 166 C
|
|
7 |
 |
1.38 |
1.79 |
62.2 |
-0.15 |
-0.09 |
9.5 |
85 |
3 |
4 |
7 |
9 |
6 |
0 |
0 |
KPI 166 B LYS 301 B LYS 301 C
|
|
8 |
 |
1.24 |
2.34 |
62.5 |
-0.20 |
-0.09 |
9.5 |
85 |
3 |
4 |
7 |
9 |
6 |
1 |
0 |
KPI 166 B LYS 301 B LYS 301 C
|
|
9 |
 |
1.00 |
1.29 |
20.8 |
-0.41 |
0.01 |
9.8 |
67 |
1 |
1 |
0 |
5 |
2 |
0 |
0 |
|
|
10 |
 |
1.76 |
2.17 |
23.1 |
-1.12 |
-0.48 |
20.6 |
91 |
2 |
3 |
3 |
1 |
1 |
0 |
0 |
LYS 301 F ACT 303 F
|
|
11 |
 |
1.23 |
1.22 |
24.9 |
-0.27 |
-0.18 |
9.5 |
88 |
2 |
1 |
2 |
5 |
2 |
0 |
0 |
KPI 166 F
|
|
12 |
|
1.41 |
1.41 |
27.6 |
0.17 |
0.12 |
8.5 |
86 |
2 |
1 |
2 |
7 |
2 |
0 |
0 |
KPI 166 F
|
|
13 |
|
1.73 |
2.17 |
28.8 |
-1.18 |
-0.36 |
19.3 |
89 |
4 |
3 |
4 |
1 |
2 |
0 |
0 |
LYS 301 E LYS 301 F
|
|
14 |
|
1.20 |
1.27 |
33.6 |
-0.62 |
-0.32 |
15.9 |
86 |
2 |
3 |
2 |
5 |
3 |
0 |
0 |
KPI 166 F LYS 301 F ACT 303 F
|
|
15 |
|
1.18 |
1.26 |
39.3 |
-0.90 |
-0.28 |
16.4 |
87 |
4 |
3 |
4 |
5 |
3 |
0 |
0 |
LYS 301 E KPI 166 F LYS 301 F
|
|
16 |
|
1.49 |
1.52 |
49.8 |
0.03 |
-0.11 |
7.6 |
87 |
2 |
2 |
7 |
8 |
5 |
0 |
0 |
KPI 166 E LYS 301 E LYS 301 F
|
|
17 |
|
1.21 |
1.27 |
60.3 |
0.07 |
-0.08 |
7.0 |
86 |
2 |
2 |
7 |
12 |
7 |
0 |
0 |
KPI 166 E LYS 301 E KPI 166 F LYS 301 F
|
|
18 |
|
1.36 |
1.54 |
22.3 |
-0.67 |
-0.18 |
13.4 |
70 |
3 |
1 |
0 |
3 |
2 |
0 |
0 |
|
|
19 |
|
1.27 |
1.33 |
18.4 |
-0.86 |
-0.40 |
16.4 |
79 |
2 |
2 |
2 |
2 |
1 |
1 |
0 |
|
|
20 |
|
1.27 |
1.32 |
21.7 |
-0.40 |
-0.22 |
13.4 |
78 |
2 |
2 |
2 |
2 |
1 |
1 |
0 |
|
|
21 |
|
1.27 |
1.40 |
16.6 |
-0.39 |
-0.14 |
15.8 |
84 |
2 |
2 |
1 |
3 |
1 |
1 |
0 |
|
|
22 |
|
1.33 |
1.53 |
16.1 |
-0.45 |
-0.23 |
14.3 |
77 |
2 |
2 |
1 |
2 |
1 |
1 |
0 |
|
|
23 |
|
1.39 |
1.54 |
16.6 |
-0.39 |
-0.24 |
12.4 |
81 |
2 |
2 |
2 |
2 |
0 |
1 |
0 |
|
|
24 |
|
1.28 |
1.63 |
17.3 |
-0.69 |
-0.29 |
15.2 |
82 |
2 |
2 |
2 |
2 |
0 |
1 |
0 |
|
|
25 |
|
1.13 |
1.42 |
16.6 |
-0.54 |
-0.22 |
15.4 |
87 |
2 |
2 |
1 |
2 |
0 |
1 |
0 |
|
 |
26 |
|
1.18 |
2.97 |
18.2 |
-0.56 |
-0.25 |
15.7 |
81 |
2 |
2 |
1 |
2 |
0 |
1 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
Residue-type_colouring |
 |
|
|
|
Positive
|
Negative
|
Neutral
|
Aliphatic
|
Aromatic
|
Pro & Gly
|
Cysteine
|
|
H,K,R
|
D,E
|
S,T,N,Q
|
A,V,L,I,M
|
F,Y,W
|
P,G
|
C
|
|
|
|
MOLE 2.0 program